Disease modification in multiple sclerosis.
Sheerani
M
M
Department of Neurology, Liaquat National Hospital, Karachi.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007372:Interferons / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000473:pathology
D000276:Adjuvants, Immunologic; D007166:Immunosuppressive Agents; D007372:Interferons